Prescription drug · ANDA
Testosterone NDC 21922-109
Testosterone 30 mg/1.5mL · Solution · Topical · Encube Ethicals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 21922-109-16 | 2192201091621922010916 | 1 BOTTLE in 1 CARTON (21922-109-16) / 110 mL in 1 BOTTLEMarketed from Jun 19, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Testosterone
- Generic name (nonproprietary)
- testosterone
- Active ingredients
- Testosterone — 30 mg/1.5mL
- Dosage form
- Solution
- Route
- Topical
- Labeler
- Encube Ethicals, Inc.NDC labeler code 21922
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212301
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
- Identifiers
- Product ID 21922-109_5b7c3fc7-5f57-4a3f-a7a0-b1f9fcf4e0f1SPL ID 5b7c3fc7-5f57-4a3f-a7a0-b1f9fcf4e0f1SPL set ID ca5d4865-356b-45e7-b603-fe299e450abcRxCUI 1599949UNII 3XMK78S47O
- Pharmacologic class
- Androgen
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N421922010916followed by a unit qualifier and the quantityPackage 21922-0109-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired); testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum concentrations and gonadotropins (FSH, LH) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropic or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma…
Excerpt only. Read the full label for complete information.
About NDC 21922-109
- What is NDC 21922-109?
- 21922-109 is the product NDC for Testosterone, Testosterone 30 mg/1.5mL solution, listed with the FDA by Encube Ethicals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Testosterone.
- What is the active ingredient?
- Testosterone.
- Who is the labeler?
- Encube Ethicals, Inc., NDC labeler code 21922. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Testosterone?
- 42 other product NDCs are listed under this name. See all Testosterone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Testosterone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Testosterone | Testosterone 25 mg/2.5g | GelTransdermal | Prasco Laboratories | 66993-954 | 66993-0954-30 |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | Prasco Laboratories | 66993-951 | 66993-0951-88 |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | Prasco Laboratories | 66993-952 | 66993-0952-30 |
| Testosterone | Testosterone 12.5 mg/1.25g | GelTransdermal | Prasco Laboratories | 66993-953 | 66993-0953-44 |
| Testosterone | Testosterone 50 mg/5g | GelTransdermal | Prasco Laboratories | 66993-955 | 66993-0955-30 |
| Testosterone | Testosterone 30 [hp_X]/1 | TabletOral | Zoe Processing | 44117-0003 | 44117-0003-01 |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | Encube Ethicals, Inc. | 21922-030 | 21922-0030-2021922-0030-52 |
| Testosterone | Testosterone 20.25 mg/1.25g | Gel, MeteredTransdermal | Northstar Rx LLC | 72603-265 | 72603-0265-01 |
| Testosterone | Testosterone 25 mg/2.5g | GelTransdermal | Strides Pharma Science Limited | 64380-151 | 64380-0151-02 |
| Testosterone | Testosterone 50 mg/5g | GelTransdermal | Strides Pharma Science Limited | 64380-152 | 64380-0152-02 |